Lilly's $2.75B generative chemistry deal and why AI research might be locked into 'hypernormal' science
Weekly Tech+Bio Highlights #79: A Pharma…
Lilly's $2.75B generative chemistry deal and why AI research might be locked into 'hypernormal' science